Ghent University Hospital
Ghent, 9000, Belgium
Location status: Recruiting
NCT Number: NCT07315646
Rationale: The 2019 Belgian Health Survey shows that the combined oral contraceptive pill is the most commonly used form of contraception. However, the Pearl index of Long-acting reversible contraceptive (LARC) methods is significantly better (perfect and typical use <0.5) compared to the combined oral contraceptive pill (perfect use <1.0, typical use 2-9). An IUS is an example of a LARC method. IUS insertion might be painful. Because of this, women may be reluctant to opt for an IUS. The traditional technique for an IUS insertion uses a speculum after which a Pozzi tenaculum is placed on the cervix so that the uterus is brought into the stretching position by means of traction. The cavum is then measured by a uterine sound. These actions and the use of these instruments can contribute to the pain experience during insertion. The new technique, transabdominal sonographic (TAS) insertion, could reduce the pain experience during insertion. This new technique uses transabdominal sonography during IUS placement. The placement under constant visualization eliminates the need for Pozzi tenaculum and uterine soundings. Little high quality studies have been conducted on the advantages and disadvantages of the TAS technique as demonstrated by a non-published systematic review of the literature.
Research question/goal: Is the insertion of an IUS (Kyleena/Mirena) using the TAS technique less painful than the traditional technique?
Study design: A randomized trial (RCT) in which the subject is blinded to the insertion technique.
Study population: Women wishing an IUS (Kyleena & Mirena)
Primary and secondary outcomes:
The primary outcomes are the pain during insertion (Numeric Rating Scale (NRS) score 0-10) and dislocation: non-fundal position (> 3mm fundal distance postinsertion) in the uterine cavity (Y/N).
Secondary outcomes include the average and worst pain in the first week after insertion (NRS 0-10), expulsion of the IUS, perforation of the uterine wall, failure of insertion, the occurrence of vagal symptoms, use of pain relief the first 7 days after placement, subject satisfaction about the procedure, successful IUS placement.
Interested in participating?
Request Info18 year–60 year
Female
Interventional
Not applicable
Ghent, 9000, Belgium
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intra-uterine device insertion (technique based on randomization arm)
Time frame: From enrollment to the intervention date (IUS placement)
Pain during insertion, reported by the subject on a Numeric Rating Scale (NRS scale) 0-10
Time frame: From enrollment to intervention date (IUS placement)
Dislocation: non-fundal position (> 3mm fundal distance postinsertion) in the uterine cavity (Y/N)
Time frame: During of directly after the intervention (IUS placement)
Expulsion of the IUS during the procedure (Y/N)
Time frame: During the procedure of IUS placement
Failure of insertion (yes/no)
Time frame: During IUD insertion
Vagal symptoms: paillor, sweating, syncope (yes/no)
Time frame: During the 7 days after IUS insertion
Pain experience (average and worst pain) during 7 days after placement (NRS 0-10)
Time frame: During the 7 days after IUS placement
Pain relief taken during the 7 days after placement (Y/N, if yes specify in text field (what, dose, timing))
Time frame: Seven days after IUS placement
Subject satisfaction with the technique (5 point Likert scale)
Time frame: Directly after IUS insertion procedure
Successful IUS placement (Y/N)
Time frame: During IUS placement
Perforation: IUS perforates the uterine wall (Y/N). Characterized by sharp pain and blood loss during insertion, ultrasound extrauterine position in total perforation or positioned in the myometrium in partial perforation.
Contact information is provided by the study sponsor or research team.
Margot Van Geyte, MD
CONTACT
Study team Gynaecology & Obstetrics UZ Gent
CONTACT
University Hospital, Ghent
Other
The PAINLESS Study: Pain Associated wIth traditioNal Versus uLtrasound guidEd iuS (Intra Uterine System) inSertion
Acronym: PAINLESS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06969365
Anxiety Disorders, Intra-uterine Device Placement
Kansas City, Missouri, United States
View Trial Details